Form 4: Sylebra Capital Plans Impinj Stock Sale Under 10b5-1

Sylebra Capital LLC, an investment sub-adviser, reported a planned sale of 3,772 shares of Impinj Inc. common stock at $156.3 per share, effective November 12, 2025, under a 10b5-1 plan.

Summary

• Sylebra Capital LLC, an investment sub-adviser, filed a Form 4 indicating a planned transaction.
• The transaction involves the disposition of 3,772 shares of Impinj Inc. Common Stock.
• The sale price per share is $156.3.
• The transaction date is November 12, 2025.
• Following this planned transaction, the reporting persons will beneficially own 1,764,572 shares indirectly.
• The transaction is made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-arranged.
• Daniel Patrick Gibson, a director of Impinj Inc., is associated with Sylebra Capital LLC and its related entities (Sylebra Capital Limited, Sylebra Capital Management).
• Sylebra Capital Limited, Sylebra Capital LLC, Sylebra Capital Management, and Daniel Patrick Gibson disclaim beneficial ownership of these securities, except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: This is a routine disclosure of a pre-planned insider stock sale under a 10b5-1 plan. The transaction amount is relatively small compared to the total beneficial ownership, suggesting it's likely for portfolio management rather than a significant change in outlook.

Positives

• The transaction is part of a pre-arranged Rule 10b5-1 plan, indicating it is not a reactive sale based on new, non-public information.

Negatives

• A planned sale by an investment entity associated with a director could be perceived as a slight reduction in insider confidence, although the amount is relatively small compared to total holdings.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Sylebra Capital LLC, an entity associated with Impinj Inc. director Daniel Patrick Gibson, reported a planned sale of Impinj common stock.

Stakeholder Impact

• Shareholders: A minor, pre-planned reduction in holdings by an investment entity associated with a director, unlikely to have a significant impact on share price or long-term sentiment.

Key Dates

Recommendation

The filing details a pre-planned sale of a relatively small number of shares by an investment entity associated with a director, executed under a Rule 10b5-1 plan. This type of transaction is generally considered routine and does not typically signal a material change in the company's fundamentals or future prospects that would warrant a change in investment recommendation. Investors should consider this a standard portfolio adjustment rather than a bearish signal.

Keywords

Impinj, PI, Sylebra Capital, Form 4, 10b5-1 plan, insider transaction, stock sale, beneficial ownership, Daniel Patrick Gibson